For drug products that include placebo tablets, how many batches (of placebo tablets) are required for submission? Is 6 months of stability data on the placebo tablets needed if the ANDA is submitted after the June 2014 deadline?

One batch of placebo tablets with full CMC information should be included at
the time of ANDA submission; however, the final packaging presentation
(containing the placebo tablets) should have data from accelerated and long term
stability testing. Six months of accelerated and long-term stability data
are recommended for the entire packaging presentation including placebo
tablets, where applicable, at the time of submission.